ReviewBiochemistry and biophysics reports2026
Biological functions of tsRNAs and research advances in human disease.
Review in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
tsRNAs (tRNA-derived small RNAs) are a class of noncoding small RNAs generated by nuclease-specific cleavage of mature tRNAs or their precursors. Since their functional discovery in 2009, tsRNAs have emerged as a research hotspot in molecular biology and medicine because of their unique generation mechanism, tissue-specific expression patterns, and diverse regulatory functions. Compared with traditional non-coding RNAs (such as miRNAs and lncRNAs), tsRNAs exhibit distinct biological activities in stress responses, translational regulation, and epigenetic modifications and are closely associated with the onset and progression of various human diseases. This systematic review covers the discovery history, classification characteristics, primary biological functions, and action mechanisms of tsRNAs in major diseases, including respiratory disorders, neuropsychiatric conditions, cardiovascular diseases, and tumors. It further explores the clinical translational potential of tsRNAs as disease biomarkers and therapeutic targets, identifies current challenges, and outlines future research directions. Major knowledge gaps highlighted include the lack of standardized detection methods for tsRNA subtypes, unclear specificity of their molecular targets in pathological processes, and limited validation in large clinical cohorts; key challenges involve inefficient delivery of tsRNA-based therapeutics and insufficient exploration of cross-species conservation. The review aims to provide a comprehensive reference for in-depth studies in the field of tsRNA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.